Physician profile
James Patrick Greelish
NPI 1306933411
$2,894.82
in general payments reported to CMS, 2019-2025
7 companies · $68.86 in 2025
The $68.86 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,739 · 2020: $247 · 2021: $100 · 2022: $212 · 2023: $409 · 2024: $119 · 2025: $68.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,986.28 | 2019-2020 | |
| Abiomed | $313.99 | 2023-2025 | Impella |
| Abbott Laboratories | $211.82 | 2022 | |
| Boston Scientific Corporation | $136.05 | 2023 | Watchman Access System |
| Edwards Lifesciences Corporation | $132.00 | 2023-2024 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $101.58 | 2021-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Greelish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.